Back to mobile site

WAVE Life Sciences (WVE) PT Lowered to $39 at Clear Street, 'we think ‘007 should find its optimal patient population'

March 26, 2026 4:21 PM EDT Send to a Friend
Clear Street analyst Bill Maughan lowered the price target on WAVE Life Sciences (NASDAQ: WVE) to $39.00 (from $50.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login